90 related articles for article (PubMed ID: 6383323)
1. Chronic bacterial infection models for BRM screening.
Dickneite G; Schorlemmer HU; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):174-82. PubMed ID: 6383323
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cell-mediated immunity by bestatin correlates with reduction of bacterial persistence in experimental chronic Salmonella typhimurium infection.
Dickneite G; Kaspereit F; Sedlacek HH
Infect Immun; 1984 Apr; 44(1):168-74. PubMed ID: 6368392
[TBL] [Abstract][Full Text] [Related]
4. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
5. Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
Bruley-Rosset M; Florentin I; Kiger N; Schulz J; Mathé G
Immunology; 1979 Sep; 38(1):75-83. PubMed ID: 159863
[TBL] [Abstract][Full Text] [Related]
6. [Induction of macrophage activation with bacterial products for potentiation of resistance to some chronic infections].
Oprescu CC; Olinescu A; Iancu L; Babeş S
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(4):213-20. PubMed ID: 107569
[TBL] [Abstract][Full Text] [Related]
7. Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection.
Minagawa S; Ohyama C; Hatakeyama S; Tsuchiya N; Kato T; Habuchi T
J Urol; 2005 Jun; 173(6):2171-4. PubMed ID: 15879881
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
9. Immunopotentiation in infectious disease, II. Effect of bestatin on experimental infection.
Ormrod DJ; Clarke IA; Miller TE
Chemioterapia; 1985 Aug; 4(4):324-8. PubMed ID: 3902258
[TBL] [Abstract][Full Text] [Related]
10. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Mathé G
Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
[TBL] [Abstract][Full Text] [Related]
11. [Comparative studies of the paraspecific immunostimulation (paramunization) by bacterial lysates in bacterial infection models and in the cytotoxicity test].
Wieler L; Baljer G; Büttner M; Adler J; Mayr A
Zentralbl Veterinarmed B; 1990 Sep; 37(7):491-500. PubMed ID: 2220182
[TBL] [Abstract][Full Text] [Related]
12. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
14. [Determination of the anti-infective action of an immunomodulator. Biostim as an example].
Ounis I
Allerg Immunol (Paris); 1991 Apr; 23(4):145-52. PubMed ID: 2069688
[TBL] [Abstract][Full Text] [Related]
15. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection.
Salageanu A; Ceacareanu B; Popescu D; Istrate N; Szegli G
Roum Arch Microbiol Immunol; 1997; 56(1-2):17-26. PubMed ID: 9558972
[TBL] [Abstract][Full Text] [Related]
16. Screening of small molecular microbial products modulating immune responses and bestatin.
Umezawa H
Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
[TBL] [Abstract][Full Text] [Related]
17. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
Barchielli M; Coppi G
Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
[No Abstract] [Full Text] [Related]
18. The NCI preclinical screen of biological response modifiers.
Talmadge JE; Fidler IJ; Oldham RK
Behring Inst Mitt; 1984 May; (74):189-94. PubMed ID: 6206841
[TBL] [Abstract][Full Text] [Related]
19. Induction of anti-Escherichia coli activity in mice by phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
Motohashi N; Sakagami H; Komatsu N; Fujimaki M; Wada C; Molnar J
In Vivo; 1992; 6(6):585-8. PubMed ID: 1296806
[TBL] [Abstract][Full Text] [Related]
20. Urinary immunoglobulin excretion in induced urinary infection.
Uehling DT
Invest Urol; 1972 Mar; 9(5):408-10. PubMed ID: 4552604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
